Usana Health Sciences (USNA) Amortization of Deferred Charges (2021 - 2026)

Usana Health Sciences (USNA) has reported Amortization of Deferred Charges for 6 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Amortization of Deferred Charges fell 20.67% year-over-year to $1.5 million; the TTM figure through Apr 2026 stood at $6.7 million (down 12.05% YoY), while the FY2026 annual figure was $7.1 million, down 7.15% from the prior year.
• Amortization of Deferred Charges retreated to $1.5 million in Q2 2026 per USNA's latest filing, from $1.7 million in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $2.3 million in Q2 2022 and bottomed at $1.5 million in Q2 2026.
• Historically, Amortization of Deferred Charges has averaged $1.9 million across 5 years, with a median of $1.9 million in 2025.
• Annual changes were most pronounced in 2023 — Amortization of Deferred Charges increased 8.04% — and 2026, when it slipped 20.67%.
• Usana Health Sciences' Amortization of Deferred Charges stood at $2.0 million in 2022, then retreated by 0.05% to $2.0 million in 2023, then declined by 3.78% to $1.9 million in 2024, then decreased by 12.57% to $1.6 million in 2025, then retreated by 8.25% to $1.5 million in 2026.
• Business Quant data shows USNA's Amortization of Deferred Charges at $1.5 million in Q2 2026, $1.7 million in Q1 2026, and $1.6 million in Q3 2025.